Company intelligence / Profile preview
Tetra Bio-Pharma Inc.
Orleans, Ontario, Canadatetrabiopharma.com ↗
- Ownership
- Private
- Employees
- ~33
- Development stage
- Other
01
Overview
The company had several clinical programs including REBORN1 Phase 2 trial evaluating QIXLEEF against morphine for cancer pain, and was developing various cannabinoid-derived products for multiple indications
- Therapeutic areas
- PulmonologyOphthalmologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Cannabinoid-derived drugs
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
AvicannaIntelGenx CorpAphriaCellvera Global Holdings LLC
Beyond the preview
Go deeper on Tetra Bio-Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tetra Bio-Pharma Inc..